Skip to main content

Table 5 Annual NTMLD-related direct medical costs per patient in Canada, France, Germany, and the United Kingdom

From: The cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study

Country

Annual direct medical cost per patient

Mean

Standard deviation

Median

Range

Local currency

 Canada (2015 $)

16,209

(15,168)

10,832

(808–66,503)

 France (2015 €)

17,881

(17,449)

14,724

(2,145 - 68,907)

 Germany (2015 €)

11,626

(13,330)

6,979

(884–61,558)

 United Kingdom (2015 £)

9,727

(9,143)

7,454

(91–33,269)

Purchasing power parity conversion (£)

 Canada (2015 £)

9,300

(8,703)

6,215

(464–38,157)

 France (2015 £)

15,264

(14,896)

12,569

(1,831 - 58,822)

 Germany (2015 £)

10,434

(11,962)

6,263

(793–55,244)

 United Kingdom (2015 £)

9,727

(9,143)

7,454

(91–33,269)